Parabilis Medicines, Inc. Operating Cash Flow
Parabilis Medicines, Inc. (PBLS) reported Operating Cash Flow of -$52.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- 2026-06-30: Net Cash Provided by (Used in) Operating Activities 6 month -$52.82M.
- 2025-06-30: Net Cash Provided by (Used in) Operating Activities 6 month -$65.24M.
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month |
|---|---|
| 2026-06-30 | -$52.82M 10-Q · filed 2026-08-13 |
| 2025-06-30 | -$65.24M 10-Q · filed 2026-08-13 |